Pacific Bioscience’s VP of Intellectual Property, Robert Reamey, claims questionable public SEC document “confidential corporate document”, but may “answer questions” in “over the telephone” negotiations.

Pacific Biosciences VP, Intellectual Property, Robert.H.Reamey, on behalf of Pacific Biosciences, claims that public SEC document Exhibit 10.7, dated June 15th 2010, is “a confidential corporate document” and cannot be released.

The document:
:EXHIBIT 10.7 from SEC file number: 333-168858, entitled:
COLLABORATION AGREEMENT between PACIFIC BIOSCIENCES OF CALIFORNIA INC and GEN PROBE INC,Dated June 15th 2010,
which shows numerous signs of alteration, is part of an ongoing question as to the legality of terms contained within it .  As we tweeted in January this year, document party, Gen Probe Inc, now part of Hologic Inc, fraudulently claims MRL’s MD Daniel Densham as Employee in order to claim Daniel Densham’s IP portfolio patent rights.

Dr Reamey then informs Mr Densham that its is “possible” that parts of the document maybe discussed as part of “telephone” negotiations.

When Mr Densham asks to discuss the situation with the board in order to address the impasse that Pacific Biosciences finds itself in, Dr.Reamey claims it is more “efficient” to talk to him and Dr Odonez.

Dr Reamey claims to have been in constant contact with Dr Odonez, PacBio’s newly appoint Chief Commercial Officer, over the entire course of the “discussions” to date. This was after Mr Densham “insisted” that Dr.Ordonez be included in the communications. Dr Reamey, however, continues to refuse to include Dr.Odenez in the email communications, no explanation is given.

Futher information will be posted on this situation, please check back for updates.

Daniel.H.Densham
Managing Director
Molecular Research Limited
mobiouscontact@protonmail.com
mobious.com